Venture Capital · London (United Kingdom), Cambridge (United Kingdom), San Francisco (United States) · Founded 1997
Amadeus Capital Partners is a venture capital firm with a 20-year track record of successful investments in technology companies. They back entrepreneurs building transformational technologies and sustainable businesses.
Seed, Series A, Series B
AI, Consumer, Cybersecurity, Digital Health, Enterprise Software, FinTech, Hardware, InsurTech, Media & Entertainment, Telecom
Aepona, Algodynamix, Altana AI, Antidote, Atmos, Atto, Axol, Baby2Body, Base4, Bellco, Brytlyt, Cambridge Touch Technologies, Charco Neurotech, Ciphergen, Congenica, Constructive Bio, ContactEngine, Creditas, Cryptosense, CSR, Descomplica, Doctify, Edgeware, Element 14, Entropic, Episerver, Epoch Biodesign, Exonar, FiveAI, FlexEnable Ltd, Fluidic Analytics, Forescout, Gemesys, Graphcore, GreenRoad, Healx, Hepstar, Hyperheat, Icera, Igenomix, Immense, Improbable, Indiamart, Ipronics, Iyzico, Kontomatik, Lastminute.com, Liquavista, Lumeon, Made.com, Natrox, Nu Quantum, Nuclera, Octo, Onedrum, Openbravo, Optos, Orchestream, Organox, Ori Biotech, Oxford Nanopore Technologies, Paragraf, Phoremost, Photonic, Pimloc, Plancq, PolyAI, Quibim, Ravelin, Refute, Riverlane, Robok, SandboxAQ, Secerno, Secondmind, Seldom, Sitehop, Slamcore, Solexa, Speechmatics, Sphere Fluidics, Sprout AI, Synthace, TCTI, Tenzo, TG0, Thinktank, Tobii, Transmode, Travelstart, Unisieve, Unlikely AI, Unruly, V7labs, Veritas International, Vocaliq, Xampla, XMOS Ltd, XYZ Reality, Zilingo